An independent Food and Drug Administration advisory panel recommended that the agency authorize Johnson & Johnson's coronavirus vaccine for emergency use.
The panel voted 22-0 on Friday in favor of the shot, which is poised to become the third cleared for use in the United States. FDA authorization could come as early as this weekend.
J&J's vaccine is given as one shot, in contrast to already authorized vaccines from Moderna and Pfizer which are given as two shots. The J&J shot also has less onerous transportation and storage requirements since it can be kept at refrigerator temperatures, rather than frozen.
Johnson & Johnson has said that it will have 4 million doses available upon authorization, with 20 million doses delivered by the end of March. The company has promised the U.S. government a total of 100 million doses by late June.
Read more here.
To change your alert settings, please go to https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings.
This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA
Please click here and follow the steps to unsubscribe.
No comments:
Post a Comment